Baseline whole-lung CT features deriving from deep learning and radiomics: prediction of benign and malignant pulmonary ground-glass nodules
Objective
To develop and validate the model for predicting benign and malignant ground-glass nodules (GGNs) based on the whole-lung baseline CT features deriving from deep learning and radiomics.
Methods
This retrospective study included 385 GGNs from 3 hospitals, confirmed by pathology. We used 239 GGNs from Hospital 1 as the training and internal validation set; 115 and 31 GGNs from Hospital 2 and Hospital 3 as the external test sets 1 and 2, respectively. An additional 32 stable GGNs from Hospital 3 with more than five years of follow-up were used as the external test set 3. We evaluated clinical and morphological features of GGNs at baseline chest CT and extracted the whole-lung radiomics features simultaneously. Besides, baseline whole-lung CT image features are further assisted and extracted using the convolutional neural network. We used the back-propagation neural network to construct five prediction models based on different collocations of the features used for training. The area under the receiver operator characteristic curve (AUC) was used to compare the prediction performance among the five models. The Delong test was used to compare the differences in AUC between models pairwise.
Results
The model integrated clinical-morphological features, whole-lung radiomic features, and whole-lung image features (CMRI) performed best among the five models, and achieved the highest AUC in the internal validation set, external test set 1, and external test set 2, which were 0.886 (95% CI: 0.841-0.921), 0.830 (95%CI: 0.749-0.893) and 0.879 (95%CI: 0.712-0.968), respectively. In the above three sets, the differences in AUC between the CMRI model and other models were significant (all P < 0.05). Moreover, the accuracy of the CMRI model in the external test set 3 was 96.88%.
Conclusion
The baseline whole-lung CT features were feasible to predict the benign and malignant of GGNs, which is helpful for more refined management of GGNs.
Top-30
Journals
|
1
2
3
4
|
|
|
Frontiers in Oncology
4 publications, 26.67%
|
|
|
European Radiology
1 publication, 6.67%
|
|
|
Advances in Clinical Medicine
1 publication, 6.67%
|
|
|
Journal of Thoracic Imaging
1 publication, 6.67%
|
|
|
Respiratory Research
1 publication, 6.67%
|
|
|
BMC Medical Imaging
1 publication, 6.67%
|
|
|
International Journal of COPD
1 publication, 6.67%
|
|
|
BMC Pulmonary Medicine
1 publication, 6.67%
|
|
|
Scientific Reports
1 publication, 6.67%
|
|
|
Respirology
1 publication, 6.67%
|
|
|
Quantitative Imaging in Medicine and Surgery
1 publication, 6.67%
|
|
|
Cureus
1 publication, 6.67%
|
|
|
1
2
3
4
|
Publishers
|
1
2
3
4
5
6
|
|
|
Springer Nature
6 publications, 40%
|
|
|
Frontiers Media S.A.
4 publications, 26.67%
|
|
|
Hans Publishers
1 publication, 6.67%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 6.67%
|
|
|
Taylor & Francis
1 publication, 6.67%
|
|
|
Wiley
1 publication, 6.67%
|
|
|
AME Publishing Company
1 publication, 6.67%
|
|
|
1
2
3
4
5
6
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.